Dr Reddy’s offers €27m for Dutch formulation firm OctoPlus
October 23, 2012Manufacturing and Production Dr Reddy's, OctoPlus, outsourcing
India’s Dr Reddy’s Laboratories has signed an agreement to buy Netherlands-based formulation and drug delivery specialist OctoPlus in a €27m …
WuXi cuts ribbon on biologics plant
October 23, 2012Manufacturing and Production CGMP, WuXi AppTec
China’s WuXi AppTec has officially opened a new biologics manufacturing facility that forms the centrepiece of the company’s recently-signed alliance …
Pfizer buys NextWave Pharmaceuticals
October 23, 2012Sales and Marketing ADHD, Pfizer, Qullivant, nextwave
Pfizer is to acquire NextWave Pharmaceuticals by the end of the year in a deal that could be worth $680 …
Amgen’s Roger Perlmutter joins Heptares
October 23, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Heptares, Roger Perlmutter
GPCR drug discovery firm Heptares Therapeutics has elected Dr Roger Perlmutter, the former executive VP, Research and Development, at Amgen …
Coping with transformational change – the key to winning
October 22, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Moorhouse
Imagine you are investing £3.4 billion in changing your business, half of it in business-critical projects such as drug supply …
Catalent licenses taste-masking technology
October 22, 2012Manufacturing and Production Catalent, taste
Catalent Pharma Solutions has licensed a new taste-masking technology that can make “even the most challenging, unpleasant and bitter tasting …
Abbott pulls kidney disease trial
October 22, 2012Research and Development, Sales and Marketing Abbott, Reata, kidney
Abbott has terminated its Phase III trial of bardoxolone methyl in patients with kidney disease and diabetes after concerns over …
AP Pharma appoints Robert Rosen as senior VP and chief commercial officer
October 22, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing AP Pharma, Robert Rosen
Specialty pharma firm AP Pharma has announced the appointment of Robert Rosen as senior vice president and chief commercial officer. …
Humira continues to drive Abbott
October 22, 2012Sales and Marketing AbVie, Abbott, Humira, RA
Abbott Laboratories’ rheumatoid arthritis drug Humira has once again shown its value to the company with a strong performance in …
NHS prescribing costs fall
October 22, 2012Sales and Marketing NHS, VBP, prescribing
The Department of Health’s annual report and accounts for 2011-2012 highlights the increasing pressure on the pharma industry to deliver …
OPEN Health acquires market access specialists pH Associates
October 19, 2012Medical Communications Harvey Walsh, Open Health, pH Associates
OPEN Health Communications is to acquire pH Associates, a consultancy specialising in ‘Real World Data’ and market access issues.The health …
Merck signs Theravance cardio deal
October 19, 2012Sales and Marketing Merck, Theravance, cardiovascular
Merck has signed a deal with US biopharma firm Theravance to discover and develop novel small molecules to treat cardiovascular …
Mylan buys Indian oncology plant for $33m
October 18, 2012Manufacturing and Production API, Mylan, SMS
Indian contract research and manufacturing services (CRAMS) company SMS Pharmaceuticals has sold its manufacturing facility in Andhra Pradesh to US …
ABPI slams NHS findings
October 18, 2012Sales and Marketing ABPI, Lucentis, NICE, UK
The ABPI has expressed concern at a report by the NHS’s Health and Social Care Information Centre (HSCIC) which suggests …
Amgen appoints senior VP and chief compliance officer
October 18, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cynthia Patton
Amgen has announced the appointment of Cynthia Patton to senior vice president and chief compliance officer. Patton will report to …
India plans ban on branded generics
October 18, 2012Manufacturing and Production, Sales and Marketing India, generics
India is moving ahead with plans to ban the sale of branded generics in the country, adding to marketplace concerns …
NICE publishes first off-label summary
October 18, 2012Sales and Marketing NICE, UK, prescribing
In a radical change to its modus operandi, NICE has published the first in an ongoing series of assessments of …
J&J profits down in Q3
October 17, 2012Sales and Marketing J&J, JJ, Johnson & Johnson, Q3, Risperdal
Johnson & Johnson has reported a 6.5% year-on-year sales increase to $17.1 billion in the third quarter of 2012, a …
Nicholson warning over NHS reforms
October 17, 2012Sales and Marketing CCGs, NHS, Nicholson, reforms
Sir David Nicholson, chief executive of the NHS, has warned that reform of the NHS could end in ‘misery and …
Edelman appoints new head of Health Public Affairs
October 17, 2012Medical Communications, Sales and Marketing Camilla Horwood, Edelman
Edelman the world’s largest PR firm has appointed Camilla Horwood to a new role as UK head of Health Public …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
